Cite

    K J Schmitz et al.. “Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neu signalling pathways.” Journal of clinical pathology, vol. 59, no. 7, 2006, pp. 685–691. http://access.bl.uk/ark:/81055/vdc_100135129026.0x000033